Does a Market Downturn Change Settlement Offers (2026)

How an offer is actually computed

Strip away the language and a life settlement offer is a discounted cash flow with one uncertain variable.

The buyer projects a stream: it will pay premiums every year until the insured dies, and at that point it receives the death benefit. It then discounts that stream at a required rate of return. The offer is the present value of the death benefit, minus the present value of all projected premiums, minus transaction and servicing costs, minus the buyer’s required margin.

Three inputs drive the result. Life expectancy, produced by independent medical underwriting firms that translate medical records into a mortality multiplier and a projected median survival, sets how long the premium stream runs and when the benefit arrives. The premium load, meaning the minimum cost to keep the contract in force to and beyond life expectancy, is a direct subtraction. The discount rate, which reflects the buyer’s cost of capital plus a risk premium, determines how much the future death benefit is worth today.

The discount rate is where market conditions enter. On a policy with a projected life expectancy of eight years, moving the discount rate from 12 percent to 15 percent reduces the present value of the death benefit by roughly a fifth, and because the premium stream is subtracted at the same rate, the net effect on the offer is amplified. That is why the same policy can draw materially different bids in different years. The full mechanics are at how buyers price a policy and the underwriting piece at life expectancy underwriting.

What actually moves an offer, ranked

Ranked by how much each variable typically changes the number, largest first. Note where market conditions land.

1. Health and life expectancy. Dominant, by a wide margin. A shift from a 12-year to a 6-year projected life expectancy can multiply an offer several times over. Nothing else on this list comes close.
2. Attained age. Correlated with the above and independently important. The market is thin below 70 and deep above 78.
3. Ongoing premium as a percentage of face. A policy costing 1.5 percent of face annually is far more valuable than an identical face amount costing 6 percent. This is why guaranteed universal life with an efficient no-lapse structure prices well.
4. Face amount. Fixed costs of diligence are roughly constant, so a $2 million policy carries them better than a $150,000 policy. Below about $100,000 most buyers do not participate at all.
5. Policy type and carrier. Universal life is the core of the market. Term is generally purchasable only if convertible, and the conversion deadline governs. Carrier financial strength matters at the margin.
6. Cost of capital and the discount rate. Real, and the subject of this page, but fifth on the list. In ordinary conditions it moves offers by a modest percentage rather than by a multiple.
7. Competitive tension in the auction. How many providers actually bid. This is often worth more than the macro environment and it is the one variable a seller can influence, by shopping the policy properly. See comparing multiple offers.

If a policy received no bid at all, the cause is almost always in the top four, not the sixth. That diagnosis is at why a policy gets no offers.

2008 and 2022: two different kinds of downturn

2008 to 2010 was a liquidity event. The financial crisis withdrew institutional capital from the secondary market abruptly. Several providers stopped bidding entirely, some exited, and the practical problem was not that offers were low but that there were no offers. Sellers who needed to transact simply could not. The market also had a structural overhang from the stranger-originated life insurance abuses of the mid-2000s, which had damaged its reputation with both regulators and capital allocators.

2022 to 2023 was a rate event. The Federal Reserve raised the federal funds target by 425 basis points during 2022 and by an additional 100 basis points through mid-2023. Higher risk-free rates raised the return institutional buyers required, and offers compressed accordingly. But capital did not vanish. Buyers kept bidding at lower prices, which is a fundamentally different situation for a seller: you get a number, and you can decide whether to take it.

The lesson from comparing the two is that the risk worth worrying about is capital withdrawal, not capital repricing. Repricing costs a seller some percentage of the offer. Withdrawal costs them the option entirely. And withdrawal is unpredictable in a way that makes waiting for a good moment a poor strategy.

One honest caveat about market statistics generally. Reported figures on annual settlement volume, average payout multiples, and provider counts come from industry associations and trade publications with varying methodology, and they are not audited in the way securities market data is. Treat any single published figure as directional rather than precise.

Input	Direction	Effect on the offer	Relative weight
Shorter projected life expectancy	Down in years	Substantially higher	Highest
Higher attained age	Up	Higher	High
Higher ongoing premium	Up	Lower	High
Larger face amount	Up	Better pricing efficiency	Medium
Higher buyer cost of capital	Up	Lower	Medium-low
More bidders in the auction	Up	Higher	Medium
Improved health since last review	Better	Lower	Medium

Why waiting for a better market usually loses

Run the arithmetic on the decision to wait twelve months.

You pay another year of premiums. On a policy costing 4 percent of face annually, waiting a year costs 4 percent of face out of pocket, which frequently exceeds any plausible improvement in the offer.

You age a year, which helps. This is the one factor that moves in the seller’s favor. A shorter projected remaining life expectancy raises the present value of the death benefit.

Your health may improve, which hurts. Counterintuitive but true. An insured who recovers from a condition, stabilizes on a new medication, or simply outlives a prior life expectancy projection will typically receive a lower offer on a second look. That dynamic is covered at when improved health lowers an offer.

Deadlines may close. A term conversion rider that expires at a stated attained age is the sharpest example. Once it closes, a term policy that had real value has none.

The market may or may not improve. Nobody knows, including the people who sound confident.

Netting those, the case for waiting exists only where the insured expects a meaningful health deterioration, the premium is low relative to face, and no contractual deadline is approaching. That is a narrow set. The general timing analysis is at when to sell a policy.

If you have already received a disappointing offer

A low offer in a soft market is not automatically a bad offer, and it is not automatically a fair one either. Test it in this order.

1. Ask how many providers bid and what each one said. A broker representing you should disclose the full bid history. One bid is not a market.
2. Check the life expectancy reports used. Offers are built on them, and two underwriting firms can produce materially different projections on the same file. If only one report was ordered, ask why.
3. Confirm the premium assumption. Buyers model the minimum premium needed to sustain the policy. An overstated premium assumption suppresses the offer, and it is a correctable error.
4. Compare against cash surrender value and against reduced paid-up. If the offer does not clearly beat both, the transaction may not be worth doing at all.
5. Consider a partial sale or a retained death benefit structure, where the seller keeps a portion of the death benefit and pays no further premiums.
6. Decide whether to re-shop later, understanding that a policy shopped repeatedly can develop a reputation in a small market. See shopping a policy twice.

Practical next steps on a weak number are at what to do about a low offer, and on verifying it independently at getting a second opinion.

Options ranked, market conditions aside

1. Keep paying. If coverage is needed and affordable, market conditions are irrelevant. The death benefit is generally received income-tax-free by the beneficiary under Internal Revenue Code section 101(a), and no discount rate applies to it.
2. Reduce the face amount to cut the premium while keeping the contract alive. Costs nothing and preserves optionality.
3. Reduced paid-up. Whole life. Ends premiums permanently in exchange for a smaller guaranteed benefit. Completely insulated from capital markets.
4. Extended term. Full face, no premium, fixed years.
5. Retained death benefit structure. No cash at closing, no further premiums, and a guaranteed percentage of the face amount preserved for the family. Underused, and notably less sensitive to discount rates than a cash offer.
6. Accelerated death benefit rider, with a qualifying diagnosis.
7. Policy loan. Bridges a cash need without a permanent decision, at the cost of compounding interest against the benefit.
8. 1035 exchange, only if currently insurable at a workable rating.
9. Life settlement. The right answer when coverage is genuinely unneeded and the offer clearly exceeds surrender value and the paid-up alternatives.
10. Surrender. The price floor. Test the market first.

What makes a policy draw competitive bids in any environment is a low premium relative to face, a large face amount, an older insured, and a clean chain of ownership.

When selling is the wrong answer

• You are selling because you read that rates are falling. Macro timing is the weakest reason on the list to make a permanent decision about a family asset. The right reasons are that the coverage is no longer needed, the premium is unaffordable, or a specific cash need exists.
• The coverage is still needed by someone specific. A surviving spouse’s income, a dependent adult child, a business obligation. No offer compensates for that.
• The offer barely exceeds cash surrender value. After the process, the disclosure, the medical records release, and the wait, a marginal improvement over a surrender you could complete in two weeks is not worth doing.
• You have one bid. A single offer in a soft market is a starting point, not a price. Insist on knowing who else looked and what they said.
• The insured is under about 65 and healthy. The market will not pay well for that profile in any environment, and a weak market makes it worse.
• Proceeds would disrupt a means-tested benefit in the month received, with no spending plan in place.
• A conversion deadline is the actual issue. If the underlying problem is an expiring term policy, converting first and then evaluating almost always produces a better outcome than selling a term policy under time pressure.

Pine Lake Life Solutions offers a free, no-obligation policy review, and we will tell you plainly when the market is unlikely to pay for a policy rather than run a process that wastes your time. We are an educational resource and a broker-side advocate; we do not purchase policies. Call (305) 209-7183.

---

Frequently Asked Questions

Do settlement offers really drop when interest rates rise?

Yes, mechanically. Buyers discount a future death benefit at a required rate of return tied to their cost of capital. When that rate rises, the present value of the same future benefit falls and offers compress. The effect is real but usually modest relative to the influence of the insured’s health and age, which dominate the calculation.

Should I wait for a better market before selling?

Rarely. Waiting costs another year of premiums with certainty, may close a term conversion deadline permanently, and can produce a lower offer if health stabilizes or improves. Aging a year helps, but the combination usually nets negative. Wait only if the premium is low relative to face, no deadline is approaching, and a health decline is genuinely expected.

Is the life settlement market correlated with the stock market?

The underlying returns are not, because the payoff depends on mortality rather than on asset prices. The available capital is correlated, because the same institutions allocate across asset classes and pull back in stressed conditions. That is why 2008 produced a shortage of bidders rather than merely lower bids, which is a worse outcome for a seller.

Can I get a better price by waiting for more bidders?

Competitive tension genuinely matters and is often worth more than macro conditions, but you influence it by how the policy is shopped, not by when. A properly run process solicits multiple licensed providers simultaneously and discloses every bid to you. If you were shown one offer, ask who else received the file and what they said.

Are published life settlement market statistics reliable?

Treat them as directional. Figures on annual volume, average payout multiples, and provider counts come from industry associations and trade publications with differing methodologies, and there is no audited central reporting comparable to securities markets. They are useful for understanding trends and unreliable for predicting what any individual policy will fetch.

What is a retained death benefit and does it help in a weak market?

It is a structure where you transfer the policy, receive no cash at closing, pay no further premiums, and keep a guaranteed percentage of the death benefit for your beneficiaries. Because there is no lump sum to discount, it is somewhat less sensitive to the buyer’s cost of capital than a cash offer, which can make it comparatively attractive when discount rates are high.

Related Reading

• How Buyers Price A Policy
• What Is Life Expectancy Underwriting
• Multiple Offers Comparing
• Why My Policy Got No Offers
• Improved Health Lower Offer
• Timing When To Sell A Policy
• Shopping A Policy Twice
• Low Offer What To Do
• Second Opinion On An Offer

---

Pine Lake Life Solutions does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.